Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma

Scandinavian Journal of Rheumatology

Volumn 40, Issue 4, 2011, Pages 299-303

  Danielides, S ^a   Mavragani, C P ^a   Katsakoulas, I ^a   Zintzaras, E ^b   Drosos, A A ^c   Vlachoyiannopoulos, P G ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSE SCLERODERMA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIMITED SCLERODERMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PHENOTYPE; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; THYROID GLAND;

EID: 80051979157     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2010.549837     Document Type: Article

References (30)

1. Dayan, CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996;335:99-107 (Pubitemid 26240112)
2. Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxford), 2010, [Epub ahead of print], doi:10.1111/j.1365-2265.2010.03855.x
3. Mavragani CP, Danieledes S, Moutsopoulos HM. Systemic autoimmune manifestations: when should underlying thyroid autoimmunity be considered? Curr Rheumatol Rev 2006;2:345-8 (Pubitemid 44697199)
4. Mavragani CP, Skopouli FN, Moutsopoulos HM. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. J Rheumatol 2009;36:1626-30
5. Mavragani CP, Ioannidis JP, Tzioufas AG, Hantoumi IE, Moutsopoulos HM. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology (Oxford) 1999;38:1228-33
6. Mavragani CP, Patronas N, Dalakas M, Moutsopoulos HM. Illdefined neurological syndromes with autoimmune background: a diagnostic challenge. J Rheumatol 2007;34:341-5
7. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369-74
8. Takada K, Suzuki K, Matsumoto M, Okada M, Nakanishi T, Horikoshi H, et al. Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies. Scand J Rheumatol 2008;37:360-4
9. Rojas-Villarraga A, Toro CE, Espinosa G, Rodríguez-Velosa Y, Duarte-Rey C, Mantilla RD, et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010;9:229-32
10. Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism 2010;59:896-900
11. Del Puente A, Savastano S, Nuzzo V, Esposito A, Lupoli G. High prevalence of thyroid autoantibodies in newly diagnosed rheumatoid arthritis patients. Clin Exp Rheumatol 2003;21:137 (Pubitemid 36267549)
12. Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögrens syndrome. Thyroid 2009;19:39-45
13. Ranque B, Berezne A, Le-Guern V, Pagnoux C, Allanore Y, Launay D, et al. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010;39:498-505
14. Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA. Subclinical atherosclerosis in scleroderma patients. Scand J Rheumatol 2010;39:326-9
15. Mok MY, Chiu SS, Lo Y, Mak HK, Wong WS, Khong PL, et al. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009;38:381-5
16. Shah AA, Wigley FM. Often forgotten manifestations of systemic sclerosis. Rheum Dis Clin North Am 2008;34:221-38 (Pubitemid 351343812)
17. Gordon MB, Klein I, Dekker A, Rodnan GP, Medsger TA Jr. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 1981;95:431-5 (Pubitemid 11007369)
18. Innocencio RM, Romaldini JH, Ward LS. High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome. Clin Rheumatol 2003;22:494 (Pubitemid 41510467)
19. Kahl LE, Medsger TA Jr, Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986;13:103-7 (Pubitemid 16118733)
20. De Keyser L, Narhi DC, Furst DE, Huberman AK, Ross R, Clements J, et al. Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest 1990;13:161-9 (Pubitemid 20111832)
21. Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M, et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007;156:431-7 (Pubitemid 46672643)
22. Marasini B, Ferrari PA, Solaro N, Selmi C, Marasini B, Ferrari PA, et al. Thyroid dysfunction in women with systemic sclerosis. Ann N Y Acad Sci 2007;1108:305-11 (Pubitemid 47528743)
23. Molnar I, Balazs C, Szabo E, Czirjak L. Anti-thyroid antibodies and hypothyroidism in systemic sclerosis. Endocrinol Invest 1992;15:311
24. Hudson M, Rojas-Villarraga A, Coral-Alvarado P, Lopez-Guzman S, Mantilla RD, Chalem P, et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008;31:156-9
25. Avouac J, Airo P, Dieude P, Caramaschi P, Tiev K, Diot E, et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010;37:608-14
26. Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, et al. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol 2007;149:40-7 (Pubitemid 46897104)
27. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6 (Pubitemid 32234635)
28. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. Br Med J 1996;313:539-44 (Pubitemid 26336143)
29. Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, et al. Sjögrens syndrome in patients with the CREST variant of progressive systemic scleroderma. J Rheumatol 1991;18:1685-8
30. Badesch DB, Wynne KM, Bonvallet S, Voelkel NF, Ridgway C, Groves BM. Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med 1993;119:44-6 (Pubitemid 23177297)